Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Gravrand

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Annales D'Endocrinologie|March 22, 2026
Adrenocortical Carcinoma: From genomics to patientsVictor Gravrand, Anne Jouinot, Guillaume Assié
Journal of Genetic Counseling|June 19, 2024
A retrospective cohort study and review of the literature about germline mosaicism in Duchenne/Becker muscular dystrophy prenatal counseling: How to estimate the recurrence risk in clinical settings?Camille Verebi, Victor Gravrand, Thierry Bienvenu, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2024
Molecular insights into the evolutionary trajectory of a <i>Klebsiella aerogenes</i> clinical isolate with a complex trade-off between resistance and virulenceYoussouf Sereme, Hélène Faury, Victor Gravrand, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2022
Frameshift mutation (690delG) in cpxA contributes to the extensive drug resistance of a Serratia marcescens clinical isolateVictor Gravrand, Frédéric Ariey, Laura Terracol, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2024
Pediatric reference values of NT-proBNP and Galectin-3 based on a French cohortVictor Gravrand, Corentin S Lefebvre, Fatma Hamza, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|July 30, 2023
[Towards a generalization of non-invasive prenatal diagnosis of single-gene disorders? Assesment and outlook]Camille Verebi, Victor Gravrand, Mathilde Pacault, et al.
Viruses|February 28, 2023
Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response TestVictor Gravrand, François Mellot, Felix Ackermann, et al.
Computational and Structural Biotechnology Journal|September 24, 2025
Internal validation strategy for high dimensional prognosis model: A simulation study and application to transcriptomic in head and neck tumorsAntoine Dubray-Vautrin, Victor Gravrand, Grégoire Marret, et al.
Prenatal Diagnosis|August 13, 2025
The Value of Enhancing Sonographic Phenotyping to Improve the Diagnostic Yield of Noninvasive Prenatal Diagnosis (NIPD) for AchondroplasiaCamille Verebi, Victor Gravrand, Claire Guerini, et al.
Annales D'Endocrinologie|March 21, 2026
Nationwide implementation of exclusion non-invasive prenatal diagnosis for single-gene disorders: nine-year activity and performance analysis from the French public networkAdrien Labarthe, Solène Doppler, Marie-Pierre Audrézet, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Annales D'Endocrinologie|March 22, 2026
Adrenocortical Carcinoma: From genomics to patientsVictor Gravrand, Anne Jouinot, Guillaume Assié
Journal of Genetic Counseling|June 19, 2024
A retrospective cohort study and review of the literature about germline mosaicism in Duchenne/Becker muscular dystrophy prenatal counseling: How to estimate the recurrence risk in clinical settings?Camille Verebi, Victor Gravrand, Thierry Bienvenu, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2024
Molecular insights into the evolutionary trajectory of a <i>Klebsiella aerogenes</i> clinical isolate with a complex trade-off between resistance and virulenceYoussouf Sereme, Hélène Faury, Victor Gravrand, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2022
Frameshift mutation (690delG) in cpxA contributes to the extensive drug resistance of a Serratia marcescens clinical isolateVictor Gravrand, Frédéric Ariey, Laura Terracol, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2024
Pediatric reference values of NT-proBNP and Galectin-3 based on a French cohortVictor Gravrand, Corentin S Lefebvre, Fatma Hamza, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|July 30, 2023
[Towards a generalization of non-invasive prenatal diagnosis of single-gene disorders? Assesment and outlook]Camille Verebi, Victor Gravrand, Mathilde Pacault, et al.
Viruses|February 28, 2023
Stratification of COVID-19 Severity Using SeptiCyte RAPID, a Novel Host Immune Response TestVictor Gravrand, François Mellot, Felix Ackermann, et al.
Computational and Structural Biotechnology Journal|September 24, 2025
Internal validation strategy for high dimensional prognosis model: A simulation study and application to transcriptomic in head and neck tumorsAntoine Dubray-Vautrin, Victor Gravrand, Grégoire Marret, et al.
Prenatal Diagnosis|August 13, 2025
The Value of Enhancing Sonographic Phenotyping to Improve the Diagnostic Yield of Noninvasive Prenatal Diagnosis (NIPD) for AchondroplasiaCamille Verebi, Victor Gravrand, Claire Guerini, et al.
Annales D'Endocrinologie|March 21, 2026
Nationwide implementation of exclusion non-invasive prenatal diagnosis for single-gene disorders: nine-year activity and performance analysis from the French public networkAdrien Labarthe, Solène Doppler, Marie-Pierre Audrézet, et al.
Pageof 2